Early Cancer Detection in Dogs with a Simple Blood Draw
The cancer researchers, genomics specialists, data scientists, and veterinarians at PetDx® bring together the expertise required to deliver this breakthrough Liquid Biopsy technology for the benefit of dogs and their families.
PetDx® – The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9® employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.
Daniel S. Grosu, MD, MBA
Dr. Andi Flory, DVM, DACVIM (Oncology)
If you are eager to incorporate breakthrough innovation into your veterinary practice, we would love to partner with you. Be among the first to offer our pioneering multi-cancer early detection test to your canine patients.
